Device Trial Radar · NCT03176225
Evaluate Safety and Effectiveness of XenoSure Biological Patch in the Application of Cardiac Repair
Last checked: Nov 20, 2026Latest source record: Mar 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
142
Actual
Start
Aug 15, 2017
Primary completion
Nov 15, 2020
Study completion Feb 15, 2024
Sponsor
- Lead sponsor
- LeMaitre VascularNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 5, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, up to 6 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this clinical trial is to collect safety and effectiveness data to support cardiac repair indication of XenoSure biologic patch. This trial is performed to meet the China FDA regulations for this kind of device. The clinical trial will be performed solely inside China under GCP regulation and all applicable China regulations on medical device clinical trial.
Conditions
- Heart Diseases
Interventions
Open heart surgery to address the heart diseaseProcedure
The patient will first have open heart surgery to achieve access to the diseased site in the heart
Close the defects with XenoSure PatchDevice
The heart defects, such as ASD (Atrial Septal Defect) or VSD (Ventricular Septal Defect ), are closed with LeMaitre XenoSure Patch.
Close the defects with Chest Polyester PatchDevice
The heart defects, such as ASD (Atrial Septal Defect) or VSD (Ventricular Septal Defect ), are closed with a Polyester Patch made by Shanghai Chest Medical Technology Co.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Leakage rate at 6 month post-procedure measured by ultrasoundTime frame: 6 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Chinese PLA General Hospital
Beijing, Beijing Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.